BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

244 related articles for article (PubMed ID: 37291218)

  • 1. Targeting lymphoid-derived IL-17 signaling to delay skin aging.
    Solá P; Mereu E; Bonjoch J; Casado-Peláez M; Prats N; Aguilera M; Reina O; Blanco E; Esteller M; Di Croce L; Heyn H; Solanas G; Benitah SA
    Nat Aging; 2023 Jun; 3(6):688-704. PubMed ID: 37291218
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Neonatal-derived IL-17 producing dermal γδ T cells are required to prevent spontaneous atopic dermatitis.
    Spidale NA; Malhotra N; Frascoli M; Sylvia K; Miu B; Freeman C; Stadinski BD; Huseby E; Kang J
    Elife; 2020 Feb; 9():. PubMed ID: 32065580
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Whodunit? The Contribution of Interleukin (IL)-17/IL-22-Producing γδ T Cells, αβ T Cells, and Innate Lymphoid Cells to the Pathogenesis of Spondyloarthritis.
    Reinhardt A; Prinz I
    Front Immunol; 2018; 9():885. PubMed ID: 29922283
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dermal γδ T Cells Do Not Freely Re-Circulate Out of Skin and Produce IL-17 to Promote Neutrophil Infiltration during Primary Contact Hypersensitivity.
    Jiang X; Park CO; Geddes Sweeney J; Yoo MJ; Gaide O; Kupper TS
    PLoS One; 2017; 12(1):e0169397. PubMed ID: 28081153
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pivotal role of dermal IL-17-producing γδ T cells in skin inflammation.
    Cai Y; Shen X; Ding C; Qi C; Li K; Li X; Jala VR; Zhang HG; Wang T; Zheng J; Yan J
    Immunity; 2011 Oct; 35(4):596-610. PubMed ID: 21982596
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The cIAP ubiquitin ligases sustain type 3 γδ T cells and ILC during aging to promote barrier immunity.
    Rizk J; Mörbe UM; Agerholm R; Baglioni MV; Catafal Tardos E; Fares da Silva MGF; Ulmert I; Kadekar D; Viñals MT; Bekiaris V
    J Exp Med; 2023 Aug; 220(8):. PubMed ID: 37440178
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Vγ4 T Cells Inhibit the Pro-healing Functions of Dendritic Epidermal T Cells to Delay Skin Wound Closure Through IL-17A.
    Li Y; Wang Y; Zhou L; Liu M; Liang G; Yan R; Jiang Y; Hao J; Zhang X; Hu X; Huang Y; Wang R; Yin Z; Wu J; Luo G; He W
    Front Immunol; 2018; 9():240. PubMed ID: 29483920
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Bruton's tyrosine kinase inhibitor suppresses imiquimod-induced psoriasis-like inflammation in mice through regulation of IL-23/IL-17A in innate immune cells.
    Nadeem A; Ahmad SF; Al-Harbi NO; El-Sherbeeny AM; Alasmari AF; Alanazi WA; Alasmari F; Ibrahim KE; Al-Harbi MM; Bakheet SA; Attia SM
    Int Immunopharmacol; 2020 Mar; 80():106215. PubMed ID: 31982823
    [TBL] [Abstract][Full Text] [Related]  

  • 9. C5a/C5aR1 mediates IMQ-induced psoriasiform skin inflammation by promoting IL-17A production from γδ-T cells.
    Zheng QY; Xu F; Yang Y; Sun DD; Zhong Y; Wu S; Li GQ; Gao WW; Wang T; Xu GL; Liang SJ
    FASEB J; 2020 Aug; 34(8):10590-10604. PubMed ID: 32557852
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Skin-resident innate lymphoid cells converge on a pathogenic effector state.
    Bielecki P; Riesenfeld SJ; Hütter JC; Torlai Triglia E; Kowalczyk MS; Ricardo-Gonzalez RR; Lian M; Amezcua Vesely MC; Kroehling L; Xu H; Slyper M; Muus C; Ludwig LS; Christian E; Tao L; Kedaigle AJ; Steach HR; York AG; Skadow MH; Yaghoubi P; Dionne D; Jarret A; McGee HM; Porter CBM; Licona-Limón P; Bailis W; Jackson R; Gagliani N; Gasteiger G; Locksley RM; Regev A; Flavell RA
    Nature; 2021 Apr; 592(7852):128-132. PubMed ID: 33536623
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Age-related increase in IL-17 activates pro-inflammatory signaling in prostate cells.
    De Angulo A; Faris R; Daniel B; Jolly C; deGraffenried L
    Prostate; 2015 Apr; 75(5):449-62. PubMed ID: 25560177
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Potential role of IL-17-producing CD4/CD8 double negative αβ T cells in psoriatic skin inflammation in a TPA-induced STAT3C transgenic mouse model.
    Ueyama A; Imura C; Fusamae Y; Tsujii K; Furue Y; Aoki M; Suzuki M; Okuda T; Oshima I; Yasui K; Shichijo M; Yamamoto M
    J Dermatol Sci; 2017 Jan; 85(1):27-35. PubMed ID: 27810232
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Nociceptive sensory neurons drive interleukin-23-mediated psoriasiform skin inflammation.
    Riol-Blanco L; Ordovas-Montanes J; Perro M; Naval E; Thiriot A; Alvarez D; Paust S; Wood JN; von Andrian UH
    Nature; 2014 Jun; 510(7503):157-61. PubMed ID: 24759321
    [TBL] [Abstract][Full Text] [Related]  

  • 14. IL-17-producing ST2
    Cai T; Qiu J; Ji Y; Li W; Ding Z; Suo C; Chang J; Wang J; He R; Qian Y; Guo X; Zhou L; Sheng H; Shen L; Qiu J
    J Allergy Clin Immunol; 2019 Jan; 143(1):229-244.e9. PubMed ID: 29625134
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Selective targeting of PI3Kδ suppresses human IL-17-producing T cells and innate-like lymphocytes and may be therapeutic for IL-17-mediated diseases.
    Chen S; Paveley R; Kraal L; Sritharan L; Stevens E; Dedi N; Shock A; Shaw S; Juarez M; Yeremenko N; Baeten D; Payne A
    J Autoimmun; 2020 Jul; 111():102435. PubMed ID: 32360069
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Differential Responsiveness of Innate-like IL-17- and IFN-γ-Producing γδ T Cells to Homeostatic Cytokines.
    Corpuz TM; Stolp J; Kim HO; Pinget GV; Gray DH; Cho JH; Sprent J; Webster KE
    J Immunol; 2016 Jan; 196(2):645-54. PubMed ID: 26673141
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cellular sources of IL-17 in psoriasis: a paradigm shift?
    Keijsers RR; Joosten I; van Erp PE; Koenen HJ; van de Kerkhof PC
    Exp Dermatol; 2014 Nov; 23(11):799-803. PubMed ID: 25039885
    [TBL] [Abstract][Full Text] [Related]  

  • 18. IL-21 Controls ILC3 Cytokine Production and Promotes a Protective Phenotype in a Mouse Model of Colitis.
    Poholek CH; Dulson SJ; Zajac AJ; Harrington LE
    Immunohorizons; 2019 Jun; 3(6):194-202. PubMed ID: 31356165
    [TBL] [Abstract][Full Text] [Related]  

  • 19. IL-17A-Producing Innate Lymphoid Cells Promote Skin Inflammation by Inducing IL-33-Driven Type 2 Immune Responses.
    Kim MH; Jin SP; Jang S; Choi JY; Chung DH; Lee DH; Kim KH; Kim HY
    J Invest Dermatol; 2020 Apr; 140(4):827-837.e9. PubMed ID: 31628929
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Notch-Hes1 Signaling Regulates IL-17A
    Wang Y; Li X; Xing X; Xue H; Qi R; Ji H; Ma L
    Mediators Inflamm; 2020; 2020():8297134. PubMed ID: 32454795
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.